EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives

Claudia Parisi, Pamela Abdayem, Marco Tagliamento, Benjamin Besse, David Planchard, Jordi Remon, Gabriele Minuti, Federico Cappuzzo, Fabrice Barlesi

Cancer Treatment Reviews · 2024-12 · 131 · 102845

DOI: 10.1016/j.ctrv.2024.102845 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Treatment Reviews, 2024-12. Verfasst von Claudia Parisi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Paris-Saclay University and Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Medical and Surgical Sciences and Transl…. Hauptthemen laut MEDLINE: Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Neoadjuvant Therapy, Immunotherapy. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 104 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, Non-Small-Cell LungLung NeoplasmsNeoadjuvant TherapyImmunotherapyHumansImmune Checkpoint InhibitorsFemaleMale

Substanzen

Immune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Paris-Saclay University and Department of Medical Oncology, Gustave Roussy, Villejuif, France; Department of Medical and Surgical Sciences and Translational Medicine, St Andrea University Hospital, Sapienza University,…
  • Paris-Saclay University and Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: pamela.abdayem@gustaveroussy.fr.
  • Department of Internal Medicine and Medical Specialties, University of Genova, Genova, Italy; Department of Oncology and Hematology, IRCCS Ospedale Policlinico San Martino, Genova, Italy. Electronic address: marco.tagli…
  • Paris-Saclay University and Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: benjamin.besse@gustaveroussy.fr.
  • Paris-Saclay University and Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: david.planchard@gustaveroussy.fr.
  • Paris-Saclay University and Department of Medical Oncology, Gustave Roussy, Villejuif, France. Electronic address: jordi.remon-masip@gustaveroussy.fr.

Zitieren

APA

Parisi, C., Abdayem, P., Tagliamento, M., Besse, B., Planchard, D., Remon, J., Minuti, G., Cappuzzo, F., & Barlesi, F. (2024). Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives. Cancer Treatment Reviews, 131, 102845. https://doi.org/10.1016/j.ctrv.2024.102845

Vancouver

Parisi C, Abdayem P, Tagliamento M, Besse B, Planchard D, Remon J, et al. Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives. Cancer Treatment Reviews. 2024;131:102845. doi:10.1016/j.ctrv.2024.102845

BibTeX
@article{Parisi2024,
  author = {Parisi, Claudia and Abdayem, Pamela and Tagliamento, Marco and Besse, Benjamin and Planchard, David and Remon, Jordi and Minuti, Gabriele and Cappuzzo, Federico and Barlesi, Fabrice},
  title = {Neoadjuvant immunotherapy strategies for resectable non-small cell lung cancer (NSCLC): Current evidence among special populations and future perspectives},
  journal = {Cancer Treatment Reviews},
  year = {2024},
  volume = {131},
  pages = {102845},
  doi = {10.1016/j.ctrv.2024.102845}
}
Kostenlos starten →